Asian Pacific Journal of Cancer Prevention · 2021 · 25 citations · 44 references
The relative viable cell number of treated CL-6 cells was decreased but no effect was observed in OUMS normal cells. Furthermore, treated cells were arrested in the G0/G1 phase with down-regulation of cyclin D1 and CDK4. Annexin V/PI staining with flow cytometry analysis suggested that fucoidan could induce apoptosis in CL-6 cells. Western blot study revealed the up-regulation of apoptotic markers including Bax, cleaved PARP, cleaved caspase-3, but down-regulation of anti-apoptotic markers, cl-2. Moreover, fucoidan could induce nuclear fragmentation and chromatin condensation with alteration of ΔΨm. Conclusion: Fucoidan exerts antitumor properties against CL-6 cholangiocarcinoma cells illustrated by the induction of apoptosis and cell cycle arrest.<br />.
44
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.3K citations · Full text
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan, Brian R Davidson, Robert Goldin et al. · Gut · 2012 · 784 citations · Full text
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Juan W. Valle, Ivan Borbath, Shahid A. Khan et al. · Annals of Oncology · 2016 · 676 citations · Full text
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Paola Bertuccio, Matteo Malvezzi, Greta Carioli et al. · Journal of Hepatology · 2019 · 628 citations · Full text